-
FITC Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-21
This guide explains how to use the FITC Goat Anti-Mouse IgG (H+L) Antibody for fluorescence-based detection of mouse primary antibodies in immunofluorescence, microscopy, and flow cytometry. It is intended for mouse IgG detection and should not be used as a universal secondary for non-mouse primaries or assays that cannot resolve FITC fluorescence.
-
Biotin-Free BmTyr Proximity Labeling in T Cells
2026-09-20
The reference study develops a click-compatible BmTyr platform that uses an alkyne-phenol probe for biotin-free proximity labeling in primary T cells. Its modular chemistry supports fluorescence imaging, affinity enrichment, mass spectrometry, and antibody-independent chemiluminescent validation, while revealing chromatin-associated localization of NKAP and components of TNFα signaling.
-
FITC Goat Anti-Mouse IgG (H+L) Antibody Guide
2026-09-19
Build reproducible immunofluorescence and flow cytometry workflows around sensitive mouse IgG detection, with practical controls for signal amplification, background, storage, and live-cell compatibility. The workflow also shows how FITC readouts can support antiviral pathway studies without overstating what a secondary antibody can prove.
-
Individual SGLT2 Inhibitors in Diabetes and Heart Failure
2026-09-19
This systematic review and network meta-analysis compared five individual SGLT2 inhibitors in 20,438 patients with type 2 diabetes and heart failure, moving beyond class-level conclusions. The analysis found broad reductions in heart-failure hospitalization, but more limited evidence for meaningful differences between agents in composite cardiovascular outcomes, an important distinction for clinical interpretation and diabetes mellitus research.
-
LY2886721 BACE Inhibitor Workflow Guide
2026-09-18
Build a translational workflow around LY2886721 by connecting BACE1 target engagement, amyloid beta reduction, APP-processing biomarkers, and neuronal function. The guide emphasizes solubility-aware dosing and the paired biochemical-functional readouts needed to distinguish useful partial inhibition from assay artifacts or excessive pathway suppression.
-
Persistent rDNA Damage and PML-Nucleolar Associations
2026-09-18
Urbancokova and colleagues show that topological stress, RNA polymerase I inhibition, and targeted ribosomal DNA double-strand breaks trigger persistent PML-nucleolar associations. Their experiments connect unresolved rDNA lesions with ATM/ATR signaling, homologous-recombination processing, nucleolar compartmentalization, and senescence, providing a framework for studying nucleolar genome stability.
-
Wortmannin Workflows for PI3K/AKT Studies
2026-09-17
Use Wortmannin as a time-resolved PI3K perturbation tool for cancer signaling, ferroptosis-resistance, apoptosis assay, and autophagy experiments. This workflow translates FAT4–PI3K/AKT findings in hepatocellular carcinoma into practical controls while addressing solubility, irreversible inhibition, and concentration-dependent off-target effects.
-
Berberine Hydrochloride: Gut–Bone Workflows
2026-09-17
Berberine hydrochloride supports a layered research strategy that connects AMPK-centered metabolism with microbiome, intestinal barrier, and osteoimmune assays. This guide translates recent tuft-cell findings into practical workflows, solvent controls, comparative salt testing, and troubleshooting decisions.
-
HMGB1 Proteomics for Early Diabetic Nephropathy
2026-09-16
Peng et al. integrated quantitative serum proteomics with Mfuzz clustering and weighted gene co-expression network analysis to identify proteins associated with diabetic nephropathy progression. HMGB1 was prioritized as a candidate early-monitoring biomarker and showed increased abundance in high-glucose cellular and animal models, although clinical validation remains necessary before diagnostic use.
-
Telmisartan: AT1R Control in Cardiac Hypertrophy
2026-09-15
Telmisartan is an angiotensin II receptor antagonist that can strengthen cardiac hypertrophy experiments by separating AT1R-dependent effects from RIP3/CaMKII signaling. This guide presents an assay-design framework for hypertension research compounds, pathway controls, and cardiovascular disease research.
-
Hoechst 33342 in Fibroblast Senescence Research
2026-09-15
A translational framework for using Hoechst 33342 nuclear stain to strengthen live-cell imaging, fixed-cell analysis, and flow cytometry workflows in pterostilbene-based dermal senescence research.
-
Busulfan Workflows for DNA Damage Models
2026-09-14
Busulfan supports reproducible DNA damage, senescence, germ-cell depletion, and ovarian injury workflows when formulation, controls, and lineage-label validation are tightly coordinated. Its value is especially clear in studies that separate injury-induced remodeling from claims of new oocyte formation.
-
IFN-γ as a Lens on MASH-HCC Immune Escape
2026-09-14
Bile acid retention can make MASH-associated hepatocellular carcinoma less visible to immune surveillance by suppressing the NLRC5–MHC-I antigen-presentation axis. This article examines how Recombinant Mouse IFN-γ can serve as a defined functional challenge for testing whether metabolically compromised tumor, macrophage, and T-cell systems remain responsive to inflammatory signaling. The approach complements, rather than replaces, the reference study’s FXR and anti-PD-1 strategies and gives translational researchers a practical framework for separating antigen-presentation defects from broader cytokine-response failure.
-
Fluorouracil in Colorectal Cancer Research
2026-09-13
Build reproducible Fluorouracil workflows around thymidylate synthase inhibition, replication stress, and orthogonal cell-death readouts. This guide connects a validated HT-29 benchmark with metastatic PDX design, dose optimization, and troubleshooting for heterogeneous tumor models.
-
Cx43/NF-κB Signaling in AngII Macrophage Polarization
2026-09-12
The reference study identifies connexin 43 and NF-κB p65 as coordinated regulators of AngII-induced M1-like polarization in RAW264.7 macrophages. Its combined pharmacological, transcriptional, protein, and cytokine analyses support a Cx43/NF-κB inflammatory axis while also highlighting the limits of inferring hemichannel-specific mechanisms from inhibitor studies alone.